CNS DEPRESSANT, SEDATIVE AND ANXIOLYTIC ACTIVITY OF ETHANOLIC EXTRACT OF FRUIT OF PIPER CHABA REVEALED AFTER NEUROPHARMACOLOGICAL SCREENING
Journal Title: International Journal of Pharmacy and Pharmaceutical Sciences - Year 2014, Vol 6, Issue 11
Abstract
Objective: Different ailments can be treated by multiple approaches. Since ancient civilization plant material have been used successfully for treating diseases. Plants contain active ingredients which are beneficial for treatment of multiple diseases. The purpose of the study was to evaluate the neuropharmacological effects of ethanolic extract of fruit of Piper chaba.Methods: Piper chaba’s ethanolic extract was diluted in DMSO and administered orally at 300mg/kg according to weight of mice for 21 days. A number of tests were then performed to evaluate CNS activity.Results: The results showed reduced number of cage crossing, head dips, decreased central and peripheral square crossing, reduced struggling time in forced swim test and decreased time spends in light and dark test.Conclusion: From our results it is concluded that after acute dosing ethanolic extract of fruit of Piper chaba possesses CNS depressant, mild anxiolytic and sedative effect.Â
Authors and Affiliations
Sana Sarfaraz, Rahila Najam, Abeer Sarfaraz
Keywords
Related Articles
- EP ID EP579286
- DOI -
- Views 83
- Downloads 0
SYNTHESIS, ANTIPLASMODIAL AND ADMET STUDIES OF 4-METHYLAMINO-2-PHENYLQUINOLINE ANALOGS
Objective: Synthesis, antiplasmodial and absorption, distribution, metabolism, excretion and toxicity (ADMET) studies of 4-methylamino-2-phenylquinoline analogs. Methods: The synthesis of 4-methylamino-2-phenylquinoline...
ANALYSIS OF ORAL GLUCOSE TOLERANCE TEST USING MODIFIED ORAL MINIMAL MODEL TO DIAGNOSE OF TYPE 2 DIABETES
Objective: In this paper, a mathematical model with the new insulin system for describing the modified oral minimal model of glucose plasma levels is introduced. This model is combined with non linear least-squares metho...
EVALUATION AND PHARMACIST’S INTERVENTION FOR IMPROVING ADHERENCE AMONG RENAL FAILURE PATIENTS
Objective: Management of renal disease may include pharmacotherapy, dialysis, life style modifications, organ transplants and immunosuppressive therapy. Lack of adherence and proper perception towards prescribed renal fa...
DEVELOPMENT AND IN VIVO EVALUATION OF TOLCAPONE CONTROLLED RELEASE TRILAYER MATRIX TABLETS BY GEOMATRIX TECHNOLOGY
Objective: The present study was aimed to develop once-daily controlled release tri-layer matrix tablets of tolcapone, to achieve zero-order drug release for sustained plasma concentration by Geomatrix.Methods: Tolcapone...
FORMULATION DEVELOPMENT AND OPTIMIZATION OF TABLET CONTAINING COMBINATION OF SALAM (SYZYGIUM POLYANTHUM) AND SAMBILOTO (ANDROGRAPHIS PANICULATA) ETHANOLIC EXTRACTS
Objective: The present study was aimed at finding the appropriate type of a binder and a disintegrant which can be used formulate tablets containing a combination of two ethanol extracts of Syzygium polyanthum leaves and...